CA1227082A - Sour milk product - Google Patents
Sour milk productInfo
- Publication number
- CA1227082A CA1227082A CA000474553A CA474553A CA1227082A CA 1227082 A CA1227082 A CA 1227082A CA 000474553 A CA000474553 A CA 000474553A CA 474553 A CA474553 A CA 474553A CA 1227082 A CA1227082 A CA 1227082A
- Authority
- CA
- Canada
- Prior art keywords
- milk
- fat
- product
- water
- bifidobacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 235000021262 sour milk Nutrition 0.000 title claims abstract description 13
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims abstract description 13
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 13
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 12
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 10
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 10
- 229930006000 Sucrose Natural products 0.000 claims abstract description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 9
- 235000013681 dietary sucrose Nutrition 0.000 claims abstract description 9
- 239000008101 lactose Substances 0.000 claims abstract description 9
- 229960004793 sucrose Drugs 0.000 claims abstract description 9
- 235000013343 vitamin Nutrition 0.000 claims abstract description 8
- 239000011782 vitamin Substances 0.000 claims abstract description 8
- 229940088594 vitamin Drugs 0.000 claims abstract description 8
- 229930003231 vitamin Natural products 0.000 claims abstract description 8
- 229920001353 Dextrin Polymers 0.000 claims abstract description 7
- 239000004375 Dextrin Substances 0.000 claims abstract description 7
- 235000019425 dextrin Nutrition 0.000 claims abstract description 7
- 239000011790 ferrous sulphate Substances 0.000 claims abstract description 7
- 235000003891 ferrous sulphate Nutrition 0.000 claims abstract description 7
- 235000021243 milk fat Nutrition 0.000 claims abstract description 6
- 235000019871 vegetable fat Nutrition 0.000 claims abstract description 6
- 239000004615 ingredient Substances 0.000 claims abstract description 5
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 5
- 239000011719 vitamin A Substances 0.000 claims abstract description 5
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims abstract description 3
- 102000014171 Milk Proteins Human genes 0.000 claims abstract 2
- 108010011756 Milk Proteins Proteins 0.000 claims abstract 2
- 235000019197 fats Nutrition 0.000 claims description 12
- 239000004006 olive oil Substances 0.000 claims description 3
- 244000060011 Cocos nucifera Species 0.000 claims description 2
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 239000003925 fat Substances 0.000 claims 1
- 235000020238 sunflower seed Nutrition 0.000 claims 1
- 239000000047 product Substances 0.000 description 43
- 235000013336 milk Nutrition 0.000 description 22
- 239000008267 milk Substances 0.000 description 22
- 210000004080 milk Anatomy 0.000 description 22
- 239000000203 mixture Substances 0.000 description 19
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 230000002028 premature Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 5
- 235000013311 vegetables Nutrition 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 235000020247 cow milk Nutrition 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 229910021653 sulphate ion Inorganic materials 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 241000257303 Hymenoptera Species 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- QVFWZNCVPCJQOP-UHFFFAOYSA-N chloralodol Chemical compound CC(O)(C)CC(C)OC(O)C(Cl)(Cl)Cl QVFWZNCVPCJQOP-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000020256 human milk Nutrition 0.000 description 3
- 210000004251 human milk Anatomy 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000036649 Dysbacteriosis Diseases 0.000 description 2
- 208000027244 Dysbiosis Diseases 0.000 description 2
- 241001317374 Evides Species 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007140 dysbiosis Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 244000005706 microflora Species 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- MBEVSMZJMIQVBG-UHFFFAOYSA-N 2-(hydroxymethyl)guanidine Chemical compound NC(N)=NCO MBEVSMZJMIQVBG-UHFFFAOYSA-N 0.000 description 1
- 241000218642 Abies Species 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- 101150071986 LRAT gene Proteins 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 101100536893 Schizosaccharomyces pombe (strain 972 / ATCC 24843) thi9 gene Proteins 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- 241000193803 Therea Species 0.000 description 1
- 240000004543 Vicia ervilia Species 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000015190 carrot juice Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical group 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical group [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000009117 preventive therapy Methods 0.000 description 1
- IOVGROKTTNBUGK-SJCJKPOMSA-N ritodrine Chemical compound N([C@@H](C)[C@H](O)C=1C=CC(O)=CC=1)CCC1=CC=C(O)C=C1 IOVGROKTTNBUGK-SJCJKPOMSA-N 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000008674 spewing Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Dairy Products (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
SOUR MILK PRODUCT
Abstract A sour milk product is composed of proteins, milk and vegetable fats, lactose, dextrin maltose, saccharose, water, bifidobacteria, ferrous sulphate and vitamins A, D2, E, C, B1, B2, B3 , B6, PP with the following proportion of ingredients, in mass per cent:
milk fat 2.5 - 2.7 vegetable fat 0.8 - 1.0 lactose 2.0 - 2.2 dextrin maltose 1.6 - 1.8 saccharose 3.3 - 3.5 water 40.0 - 41.0 protein the balance, including:
bifidobacteria, cells 108 - 109 ferrous sulphate, mln-1 32.5 - 33.5 vitamins, mln-1 64.0 - 66.0
Abstract A sour milk product is composed of proteins, milk and vegetable fats, lactose, dextrin maltose, saccharose, water, bifidobacteria, ferrous sulphate and vitamins A, D2, E, C, B1, B2, B3 , B6, PP with the following proportion of ingredients, in mass per cent:
milk fat 2.5 - 2.7 vegetable fat 0.8 - 1.0 lactose 2.0 - 2.2 dextrin maltose 1.6 - 1.8 saccharose 3.3 - 3.5 water 40.0 - 41.0 protein the balance, including:
bifidobacteria, cells 108 - 109 ferrous sulphate, mln-1 32.5 - 33.5 vitamins, mln-1 64.0 - 66.0
Description
;1.~;~ 7()8Z
- SOUR MIL~' PRODUC'r ~his invention relate~ to a sour milk product.
The product can be used as in~n-t therapy di~-t during bottle-~eeding or br~a~t-~eeding of infants in their early li~e. '~he products o~ this kind have to meeb a number requi-rements. More partir,ularly, such products must b~ si~ilar in composition to 'au~an milK to po3ess high nutri~ive and biolo-gical properti~s and be highly efficlent Eor the treatmen-t of ~ysbacteriosist in~estinal infections a~d curing a~er ef-~'ects o~' antibiotic therap~.
It is Xnown that bifidobacteria are a~ integral part of the intesti~al microflora o~ a healthy breast-feeding infant, their cont~nt in the intestinal ~icro~lora normally amount-in~ to between 95 and ~8 ~.
mese bacteria ~erve to protect i~fants' bodie~ from various infections.
A dishalance in an infant 's :intestinal microflora due to lac~ of human milk dysbacteriosis, an~ibiotic therapy or intestinal infection results in a sudden decrease in the num-ber of bifidobacteria conductive to pa~h~enesis of prclonged disfunctions and metabolical failures to ver~ o~`ten cause sev~re chronical diseases in children~
Therefore~ the pro~le~ of i~te~tinal dysbacteriosis due to a disbalanced biPidoflora is raised to the concern o~
ths ge~eral biological ~clence.
It is known that disturbed i~testinal ~icro~iocenosi~
can be balanced b~ i~troducing medicinal preparation~ co~tain-ing via~le cells Qf bifidobacteria.
, . . ~ , ~
;~.Z~7(.~
~ lowever, breast-~eedi~g in:~ants mu~t pre~erably receive live cell~ of bi:~ido~acteria with food, that is with milk food which contains large amounts of ~uch bacteria.
There is known a sour milk product containing bif`idobac-teria and fabricated from whole cow's mllk.
.Ferment~ used ~or ~aking t~is product include thermo~
philic streptococcu~7 acidophilic bacilla and bif idobacteria in the ratio 5:1:1 (Milchwissenscha:~t; J.29, H.g~ 19681 B.~R:
Schuler!~aluath R~, Ruppert ~ ller Fr.."Die Mikroor~ani3-men der ~ifidusgruppe. 2. Mitteilung. Die Technologle d~r ~ifidokultur im verarbeitenden Bet-rieb, 9 S. 554-558).
~ owever9 despite the fact that the product contains bifidobacteria, it ca~not.be consumed by infants of breast-feedi~g age, since none of the ingredient~ approximates the compoqitio~ of female human ~ilk.
There i9 also known a sour milk product in which u~e is made of only pure cultures of bif.LdobaGteria. Its composition is as follows, i~ mass per cent: protein - 3.3, milX fa~ -3.3, milk sugar - 4.8, ~ineral substances - 0.~, vita~in A -more than 138 I.U.
This product is prepared Irom whole dry mil~ a~d water.
~he dry milk give~ protein~ ~at and calcium. Carrot juice is added to provide vitamin A. A~ter 10 days o~ stora~e at a temperature of about 10C the population of bi~idobacteria amount~ to over 5 billio~ liv~ c~lls in a sample of 100 ml, or 5 ^ lQ7/1 ml~ ~he product has ~ound a widespread u~e and i~ inte~ded primarily for feeding children Qf 1 year ~o pre-school age.
. . .
~;27(~82 The conk~nt o~ ~he live cell~ of bifldobacteria ma~es ; the product us~ul ~or the treatme~t and preventive therapy o~ gastroi~tes-tinal troubles, restorat,ion of di~tu.rbed ba-lance in the inte~ti~al microflora, metabolism improvement, etc. (c~. "New ~ood Industry" vol. 20, No. ~, publish~d 1978;
Mudai ~atakhiko "Characteristics of the "Marumiru" Sour Milk Product Using the 7'~ifidis" Microorganismsl', pp. 17-23).
~ owever, the above SOUI' milk product cànuot be u~ed ~or feeding newborn and premature babies, or infants of less than two ~onths after birth; it i9 definitely inapplicable to children with intestinal ~icro~lora trouble, since the product is prepared ~ro~ whole milk (protein mass content -3.3 ~; whereas protein mass co~tent in femala human milk i~1.1 to 1.7 %). It is a common ~nowledge that cow's mil`~ pro~
tein i~ le~s digestible due to underdeveloped f~rmentation system o~ the digestive tract i~ infants of breast~fe0din~
age.
I~ a~ditiou~ this sour milk product i8 dry, the dry ~our ~ilk products b~ nown to ha~e less nutritioQal ~alue than liquid or natural produot~.
The present i~vention is therefore direGted toward the pro~ision of a sour ~ product for co~sumption b~ infa~ts a~ well a~ by prematur~ and ~ewbor~ babies~ in other word~
product approximating in compo~it10n ~emale huma~ and containin~ a s;uf`ticiently large ~mou~t o~ bi~idobaeteria ~o eusura high therapeutic p.roperties.
'l`he aim of the inv~nt~on is attained by a sour mi~k pro~
':, '7(~
duct composed of` protein.9, milk ~at, milk ~u~ar, mineral substances, vitamin A, bl:~idobacteria and water~ which pro~
duct, according to the invention, additionally includes dextri~ maltose, saccharose, vegetable ~at, vitamins D2, Et C, ~1~ B2- B3, B6, Bc, PP, wherea~ u~ed as the mineral sub-.stance is ferrous-sulfate ; the relatio~hip betweerl the components bel~g as follows, in ma.Y~ per cent:
- milk fat 2.5 - 2.7 vegetable fat 0.8 - 1.0 milk sugar 2.0 ~ 2.2 .
dextri~ maltose 1.6 - 1.8 saccharose 3.3 - 3.5 water 40.0 - 41.0 proteins the balance;
the product al~o i~cluding:
bifidobacteria, ceIls 108 _ 109 fc~rous sul~ate ~in~ . 32.5 - 33.5.
~itamins1 mlm~l o4.C~ - 66.0 It ls evide~t that cow's mil~ must ~e used. as a bas~
Yor ~aki~g the propos~d Qroduct. It is also ~nown ~h~ cow's mil~ contains three ti~e~ as ~uch protei~ as female huma~
milk. Therefore, proteln content in such pr~ducu~ must ~irst be reduced to betw~en 1.5 and 1.9 7a without af~ecting their propertie~. For this purpose, water in the amouat of ~0.5 % is added to the mixture, ~hereby the protei~ content i~ brought down to 1.6 ~ g per lOQ ml or from 1 6 to 1.8 ~ o~ the total.
:. Fat accou~ts for 3O3 to 3.5 % o~ the total both for ~'~Z7~ 3Z
cow's milk ~nd ~emale numan milk. ~lowever, cow's ~ fat i5 di~ested by premature ~abies and newborns Less ca~ily than woman~s milk. Such a difference in ~i~estibility is asso-ciated wit~ the composition of fatty acids amon~ which the linoleic acid in~luencing the child's skin and welght gain plays a major role. ~ecause cow's milk contains one fi-~th o-f the linoleic acid contained in human milk, thi~ deficiency in the linoleic acid is compensated for by vegetable ~ats when producing milk mixtures for infants.
Cow's milk and human mil~ also var~ in ter~s of car -bohydrate content, mostly milk 6ugar or lactose.
Woman's milk contains 7 ~ of lactose, whereas cow's milk contains o~ly 4.7 %0 Carbohydrate content in the pro-duct i5 optimized b~ adding saccharose and malt e~tract (dextr-i~ maltose~
Saccharose i~ added to decrease the fermentatlve pro-pertie~ of lactose, whereas dextrin maltose pro~otes ~he growth o~ bifidobacteria (bifidogenlc e~fect). The ratlo betwee~ proteins, fat~ and hydrocarbons in the diet of oreast-feeding in~`ants is 1:~:5 or 1:2:4, respectively.
It ha~ been fou~d that newborn babies tend ko consu~e at a ~ery fas~ rate the build-up Qf iron received ~rom the moth~r at the fetal tage o~ developmont, whereby in the pe-riod between the age of three ~nd nine or even ten months iron deficiancy beco~es very pronou~2d.
The proposed sour mil~ produst co~tains ierrous sulphate (viz., bivalent~ more biolo~ically assimilate~ by the body) in the amou~t sufficient for optimizing iron concentratio~
'7 in breast-~eeding in~ants.
Although cow'c mil~c i~ a ver~ valuable source of vita-mins1 milk treatment and milk product storage tend to reduce vitamin content. Mil~ products inte~ded ~or inf`ants are tnere~ore vitaminized in terms of every type of vitamin, sirlce nawborns cannot compensa-te for vitamin deficiency by consum-ing meat, vegetable or other food.
~ at-soluble v~tamins A) ~2 a~d E are mixed with a ve-~etaole oil1 wherea~ water-soluble vitamins C~ PP, Bl, ~2~ ~3 B6 and Bc are dissolved i~ water or ~ to ~e therea~ter added to the mixture. The amount of vitami~s to be added ~s determi~ed by the average daily infant body needs and the overall amount of ~ product consumed by children up to two months o~ a~e.
It is recommended that corn, coconut, sunf`lower-seed or olive oils are used as the ~egetable ~at.
~ `ha proposed ~our milk product approximates in it~
compo~ition human mil~, and therefore it can be u~ed for ~eeding babie3 during af'ter-birth period9 ~s well as ~or ~eeding premature and newborn childre~. IQ addition, tha~s to a bigh conten~ o~ liv~ bifidobacteria c~lls o~ lU8 to 109 1 o~ the product, ~t can be u~ed as a~ elficient diet ~or childr~ su~'ferirlg from d~bacterios~ or int~stlnal t~o~.
'~he sou~ mil~ product accordiQg to the inre~ion wa~
prescribed by in~a~t cli~ic~ ko premature in~ants and child-re~ batween th~ aKe oY one and four month3 ~ur~ering from irltestirl~1 in~ec~ion of ~a~u~ etiology.
.. ..
rrhe product was i.ntroduced to the premature children diet gradually to eventually .replace the ba~ic ~ood. ~L'he product was ~ed both to "relatively he~lthy" premature new-borns a~d children with d~sbacteriosis treated by vigorous antibiotic therapy. The prematures consumed the product readil~ and gained in weight wit~lout any si~e e~fect~.
A daily three-meals diet of the product was prescrib~d to children sufI`e:rin~ ~ro~ intestinal in~ection for a durati-on of 21 days. ~Jithin thi9 period satisfactory assi~nilation of the sour milk product was evide~ced without any side e~fects or meal reje~ction. A gai~ in ~ei~ht for th~ period of treatment amounted to 300 g per child; paysical condition of the children improved; spewing lessened or ~erminated;
fecal discharge n~alized a~ter 1 to 4 da~s of treatment;
a gro~Yth o~ bifido~lora to 108 _ 109 per 1 g of feces ~vas in evidence.
In view of the foregoi~, t;ie proposed product can be used for Yeeding p~emature newborns and children sufLer-ing from intestinal inrec~ion.
Preparatioa o~ t~e proposed produc~ does not require high cost and acarce materials, or speci~liy designed equip-ment.
~ he method ~or obtaini~ tha proposed sour ml1~ product is suIIiciently siulple and ernploys any known suitable proce~s tachniques involving tne following sta~e~:
- ad~ission, cleanin~ and coolin~ of miik;
- normalization of miLk by cream, - homogenization OL` t~e thus obtai~ed mil; Qase with ve~eta`ole oil ana ~`~t-soluble ~i~ami ns;
. 8 - preparation o~ carbonydrate ingredient~ (sac-,hAro~e an~ malt ext~act) ;
- mixing o~ carbohydrate ingredient with rnilk ~ase;
- sterilization or pasteurization o~ the mixture;
- cooling the mixture to a souring temperature;
- addition to the mixture o~ water-soluble Yitamins and ferrous sulphate;
- ~ermentation and souring of the mixture;
- cooling of the ~inished product;
- bottling, pac~ing and labeli~g;
_ storage.
The following examples are put ~orwar~ herei~below for a better u~derstanding o~ the preser~ invention:
EX~LPLE 1 Added to 387 o~ 3.6 % fat milk and 42.4 kg of 30 ~o fat cream is 9 kg o~ cor~ oil; introduced preliminarily to this corn oil, dependin~ on the concentration in th0 oil ~olution, bein~ fat-soluble vita~ins k, ~2~ a~d ~ in the amou~t~
0.0005, 0~00001, and 0.00851 k~ re~pectiveLy~ :
X~ order to provide ~ finel;y dlspersed ~at emul~io~, the milk-fat ~ase is ho~o~e~lzed at 15-20 hl:Pa and mixed with solu~io~ o~ carbohy~Lrat~ ;redie~ts. The 301uti~ns of ~car-bohydrate l~gredl~t~ are p*epared simultaneou31y wlth ~hc prepar~ion of the m~lk bas~. Powder~d su~ar i~ the amQunt o~
~4.4 ~ and ~.5 kg o~ mal~ extrac~ having 74 '~ of dra matt~r (correspondin~ to 1~ ~ o~ dra dextri~ maltose~ are d~S~ol~d i~ 406~9 ~ o~ potable ~ater heate~ to a ~empera~u~e 48 4' 2~C, ~ilt~red throu~h a coarse ~llter and ~ixed with th~ milk-~a~
z ~ 9 ba~e. 'rhe mixt~e is thcn pa~teurized by exposing ~t to a te~perature 95 ~ 2C durillg 30 rni~utes and cooled to a tem-p~rature 44 ~ 1C.
'~hereàft~r, added to the mixture are 100 kg o~ the fer-menta of pure cultures of bi~idobacteria prepared on a ste-rile fat-free milk, 0.033 kg of f~rrous sulphate and water-solubl0 vitamin~ (solutions in boiled arld cooled water ) C, PP~ B2- B3, B6 , and Bc in the amollnts o~ 0.05, 0.004, 0.0003, 0.0001, 0.0015, 0.0002 and 0.00004, kg respactlvely~
All these ingr~dient~ are thoroughly stirred. The mixture is soured in special ve~sels for sour milk products at a tem-perature o~ 37 ~ 1C to a coagulate acidity of 45 ~ 5C, wherea~ter it is cooled and filled i~to 0.2 1 glass bottles to be stopped and delivered for cool storage.
The ~roduct may be ~tored for up t~ five days at a temperature fro~ 0C to 6C.
~he composition of the thu~ obtained product is as follows, i~ mass per ce~t:
~ilk fat Z~6 vegetabl~ ~at 0.9 qaccharose 3~4 dextri~ maltose 1.7 lacto~e 2.0 ~ater 40.7 protein tha balance, including:
bi~idobacteria, cells }09 ferrou~ sulphate~ mln 1.. ~ 33.0 vitami~s, mln~
A - 0.5 7()~
D2 - 0.01 E. - 8.5 PP ~ 4.0 B~ - 0.3 32 ~ 0.1 - 1~5 ~6 ~ 0~2 Bc ~ 0'04 EXA~PLE ~
Ad~ed to 387 ~g of 3.6 ~0 ~at milk and 4~ ~g 27.1 % ~at c:ream is 8 k~ o~ deodorized ~unflower-seed oil having prelimi-narily~introduced th~reto~ dependi~g on the conceutration in the oil solution, fat-solu~le vitamins A, D2 and E i~ the amounts 0.0005, 0~00001 and 0.0084 kg, respectlvel~.
~or obtainiQg a finely dispersed f~at emulsion the ~ilk-fat base is ho~ogenized at 15 - 20 I~Pa and mixed with so-lutions o~ caxbohydrate ingreaients~ The solutions o~ carbo-hydrate i~redients are prepared simultan~ously with the pr~paratio~ o~ the milk bass. Powdered sug~r i~ th~ amount o~
33 k~ and 24 kæ o~ malt extract:havin~ 78 '~ o~ dry matt~r (correspo~di~g to 18 kg of dr~ dextrln maltose~ are d1~solved in 400~0 kg oY potable watsr war~ed to a temperabure 48 ~ 2~
filtered through;a coarse ~iLter and ~lxed with the~ilk~`at base~ The mixture is pasteurizsd b~ expo3in~ it to~a tempara-~urs of` 95 ~ 24C duriag 30 minutes a~d cooled to 4~ C~
100 ~g o~ the ~rment of pure cultures Or `~iL}~o~cter~a p~-:' pared on a sterile ~at-~ree ~ 00325 kg o~ rrou~ sul~hate, :~ :
3~
and water-soluble vitamins (solutions in boiled a~d cooled ' 1~ B21 ~3, B6 and Bc in the amounts 0.051 0.004, .31 0.0001, 0.0015, 0.0002., and 0.00004 kg ~ res-pectively, are then introduced to the mixtureO All these i~gredie~ts are thoroughly stirred. '~he mixture i.s soured in special vessels for sour milk products at a te~perature of 37 1C to an acidity of 45 5TI1 whereafter it i9 cooled and Yilled into 0.2 1 bo-ttles` to be stopped and delivered ior cool storage. The product can be stored for up to 5 days at a temperature from 0 to 6c.
'~he composition of the thus obtained product is as follows, in mass per cent:
milk fat ~.7 vegetabl~ fat 0.8 saccharose 3.3 dextrin maltose 1.
lactose 2.1 ~iater 40-0 protei~ the balance, inclu~i~g:
bif`idobacteria, cells 109 ~errous sulphate, mln~l 32.5 vitami~s, A - 0~5 D2 - O.01 8, c _ 5 PP - ~.o Bl - 0 . 25 B2 - 0,1 B3 _ 1.5 E~6 ~ 0 . 2 ~ c w o . 04 .
EX~P~E 3 Added to 383.1 kg of 3.6 % :fat milk and 40 kg of` 27.55 %
fat cream i~ lO kg ~f olive oil having prellminarily i~tro-duced thereto, depending on the concentration irl the oil ~olution, fat-soluble vitamir~s A, D2 and E in the amau~t~
of 0.0005, 0.00001 and 0.008 k~,l respectivel;y.
For obtaining a finely dispersed fat emulsiQn the milk-fat basQ i5 homogenized a~ 15 - 20 r/lPa and mi~red with ~olutions of carbohydrats illgredie~ts. ~he solutions o~ car-bohydrate ingredie~ts are prepared sir~ultaneo~uslg with tha preparatio~ of the milk base. Powdared sugar in the amour~t o~
35 ~g and 21.9 kg of malt extract having 74 % ~f dr~ matter ~correspondillg ~o 16.2 kg o~ dr~ dextri~ maltose~ are dissol~ed i~ 410.0 i~g of potable water war~ed to 48 ~ 2G~ filtered through a~coarse ~ilter and mixed ~ith the mil,-~at bass~ The mixtuxe is pasteurized at 95 f 2C during 30 minute~ and cool-ed to ~4 ~ l~C. 100 ~ of tha ferme~t of pure ~ulture o~ bi-fidobacteria prepared on a sterile fat-fr~e mil.s, 0,0335 k~
o~ ~errou~ ~ulphate, and water-solubl~ vitamiRs (solutions in boiled a~d cooled water) C, PP, 13~ B~, B6 and ~c i~ the~
amo~nt o~ 0~04~7 O~OC)4~ 0~0003g O~OOOL~ O~C)017~ Or 0002 a~d O.Q0004 kg, respectlvel~g are then introduced to the mixture, all these bei~g thoroughly stirred, The mixt~e i~ soured i~
,~2;~ Z
-- 13 ~
vessels ;eor ~our mill~ p.roduc ts at 37 ~ 1C to arl acidi ty 0:~ 45 ~ 5~r, whereaIter i t 1~ cooled for bottllng ln 0.2 1 bottles and cool storage where the thus obtained product can be ~tored ~or up to 5 days, at a tempexa-ture of between 0C and 6c >
~he composition of the pro~uct i~ as follows, in mas~
per cent:
milk~~at 2.5 vege t abl e f at 1 . 0 saccharo~e . 3.5 dextrin ~altose 1.6 --lactose 2,0 wRter 41~0 pro~ein the balance, including-biPldobacteria, cells .,,, 108 ferrous sulphate, mln~l 33~S
vitamin~ t mln~
0.5 0~01 E - 8.4 C -49.~ -pp _4 . 0 0, 25
- SOUR MIL~' PRODUC'r ~his invention relate~ to a sour milk product.
The product can be used as in~n-t therapy di~-t during bottle-~eeding or br~a~t-~eeding of infants in their early li~e. '~he products o~ this kind have to meeb a number requi-rements. More partir,ularly, such products must b~ si~ilar in composition to 'au~an milK to po3ess high nutri~ive and biolo-gical properti~s and be highly efficlent Eor the treatmen-t of ~ysbacteriosist in~estinal infections a~d curing a~er ef-~'ects o~' antibiotic therap~.
It is Xnown that bifidobacteria are a~ integral part of the intesti~al microflora o~ a healthy breast-feeding infant, their cont~nt in the intestinal ~icro~lora normally amount-in~ to between 95 and ~8 ~.
mese bacteria ~erve to protect i~fants' bodie~ from various infections.
A dishalance in an infant 's :intestinal microflora due to lac~ of human milk dysbacteriosis, an~ibiotic therapy or intestinal infection results in a sudden decrease in the num-ber of bifidobacteria conductive to pa~h~enesis of prclonged disfunctions and metabolical failures to ver~ o~`ten cause sev~re chronical diseases in children~
Therefore~ the pro~le~ of i~te~tinal dysbacteriosis due to a disbalanced biPidoflora is raised to the concern o~
ths ge~eral biological ~clence.
It is known that disturbed i~testinal ~icro~iocenosi~
can be balanced b~ i~troducing medicinal preparation~ co~tain-ing via~le cells Qf bifidobacteria.
, . . ~ , ~
;~.Z~7(.~
~ lowever, breast-~eedi~g in:~ants mu~t pre~erably receive live cell~ of bi:~ido~acteria with food, that is with milk food which contains large amounts of ~uch bacteria.
There is known a sour milk product containing bif`idobac-teria and fabricated from whole cow's mllk.
.Ferment~ used ~or ~aking t~is product include thermo~
philic streptococcu~7 acidophilic bacilla and bif idobacteria in the ratio 5:1:1 (Milchwissenscha:~t; J.29, H.g~ 19681 B.~R:
Schuler!~aluath R~, Ruppert ~ ller Fr.."Die Mikroor~ani3-men der ~ifidusgruppe. 2. Mitteilung. Die Technologle d~r ~ifidokultur im verarbeitenden Bet-rieb, 9 S. 554-558).
~ owever9 despite the fact that the product contains bifidobacteria, it ca~not.be consumed by infants of breast-feedi~g age, since none of the ingredient~ approximates the compoqitio~ of female human ~ilk.
There i9 also known a sour milk product in which u~e is made of only pure cultures of bif.LdobaGteria. Its composition is as follows, i~ mass per cent: protein - 3.3, milX fa~ -3.3, milk sugar - 4.8, ~ineral substances - 0.~, vita~in A -more than 138 I.U.
This product is prepared Irom whole dry mil~ a~d water.
~he dry milk give~ protein~ ~at and calcium. Carrot juice is added to provide vitamin A. A~ter 10 days o~ stora~e at a temperature of about 10C the population of bi~idobacteria amount~ to over 5 billio~ liv~ c~lls in a sample of 100 ml, or 5 ^ lQ7/1 ml~ ~he product has ~ound a widespread u~e and i~ inte~ded primarily for feeding children Qf 1 year ~o pre-school age.
. . .
~;27(~82 The conk~nt o~ ~he live cell~ of bifldobacteria ma~es ; the product us~ul ~or the treatme~t and preventive therapy o~ gastroi~tes-tinal troubles, restorat,ion of di~tu.rbed ba-lance in the inte~ti~al microflora, metabolism improvement, etc. (c~. "New ~ood Industry" vol. 20, No. ~, publish~d 1978;
Mudai ~atakhiko "Characteristics of the "Marumiru" Sour Milk Product Using the 7'~ifidis" Microorganismsl', pp. 17-23).
~ owever, the above SOUI' milk product cànuot be u~ed ~or feeding newborn and premature babies, or infants of less than two ~onths after birth; it i9 definitely inapplicable to children with intestinal ~icro~lora trouble, since the product is prepared ~ro~ whole milk (protein mass content -3.3 ~; whereas protein mass co~tent in femala human milk i~1.1 to 1.7 %). It is a common ~nowledge that cow's mil`~ pro~
tein i~ le~s digestible due to underdeveloped f~rmentation system o~ the digestive tract i~ infants of breast~fe0din~
age.
I~ a~ditiou~ this sour milk product i8 dry, the dry ~our ~ilk products b~ nown to ha~e less nutritioQal ~alue than liquid or natural produot~.
The present i~vention is therefore direGted toward the pro~ision of a sour ~ product for co~sumption b~ infa~ts a~ well a~ by prematur~ and ~ewbor~ babies~ in other word~
product approximating in compo~it10n ~emale huma~ and containin~ a s;uf`ticiently large ~mou~t o~ bi~idobaeteria ~o eusura high therapeutic p.roperties.
'l`he aim of the inv~nt~on is attained by a sour mi~k pro~
':, '7(~
duct composed of` protein.9, milk ~at, milk ~u~ar, mineral substances, vitamin A, bl:~idobacteria and water~ which pro~
duct, according to the invention, additionally includes dextri~ maltose, saccharose, vegetable ~at, vitamins D2, Et C, ~1~ B2- B3, B6, Bc, PP, wherea~ u~ed as the mineral sub-.stance is ferrous-sulfate ; the relatio~hip betweerl the components bel~g as follows, in ma.Y~ per cent:
- milk fat 2.5 - 2.7 vegetable fat 0.8 - 1.0 milk sugar 2.0 ~ 2.2 .
dextri~ maltose 1.6 - 1.8 saccharose 3.3 - 3.5 water 40.0 - 41.0 proteins the balance;
the product al~o i~cluding:
bifidobacteria, ceIls 108 _ 109 fc~rous sul~ate ~in~ . 32.5 - 33.5.
~itamins1 mlm~l o4.C~ - 66.0 It ls evide~t that cow's mil~ must ~e used. as a bas~
Yor ~aki~g the propos~d Qroduct. It is also ~nown ~h~ cow's mil~ contains three ti~e~ as ~uch protei~ as female huma~
milk. Therefore, proteln content in such pr~ducu~ must ~irst be reduced to betw~en 1.5 and 1.9 7a without af~ecting their propertie~. For this purpose, water in the amouat of ~0.5 % is added to the mixture, ~hereby the protei~ content i~ brought down to 1.6 ~ g per lOQ ml or from 1 6 to 1.8 ~ o~ the total.
:. Fat accou~ts for 3O3 to 3.5 % o~ the total both for ~'~Z7~ 3Z
cow's milk ~nd ~emale numan milk. ~lowever, cow's ~ fat i5 di~ested by premature ~abies and newborns Less ca~ily than woman~s milk. Such a difference in ~i~estibility is asso-ciated wit~ the composition of fatty acids amon~ which the linoleic acid in~luencing the child's skin and welght gain plays a major role. ~ecause cow's milk contains one fi-~th o-f the linoleic acid contained in human milk, thi~ deficiency in the linoleic acid is compensated for by vegetable ~ats when producing milk mixtures for infants.
Cow's milk and human mil~ also var~ in ter~s of car -bohydrate content, mostly milk 6ugar or lactose.
Woman's milk contains 7 ~ of lactose, whereas cow's milk contains o~ly 4.7 %0 Carbohydrate content in the pro-duct i5 optimized b~ adding saccharose and malt e~tract (dextr-i~ maltose~
Saccharose i~ added to decrease the fermentatlve pro-pertie~ of lactose, whereas dextrin maltose pro~otes ~he growth o~ bifidobacteria (bifidogenlc e~fect). The ratlo betwee~ proteins, fat~ and hydrocarbons in the diet of oreast-feeding in~`ants is 1:~:5 or 1:2:4, respectively.
It ha~ been fou~d that newborn babies tend ko consu~e at a ~ery fas~ rate the build-up Qf iron received ~rom the moth~r at the fetal tage o~ developmont, whereby in the pe-riod between the age of three ~nd nine or even ten months iron deficiancy beco~es very pronou~2d.
The proposed sour mil~ produst co~tains ierrous sulphate (viz., bivalent~ more biolo~ically assimilate~ by the body) in the amou~t sufficient for optimizing iron concentratio~
'7 in breast-~eeding in~ants.
Although cow'c mil~c i~ a ver~ valuable source of vita-mins1 milk treatment and milk product storage tend to reduce vitamin content. Mil~ products inte~ded ~or inf`ants are tnere~ore vitaminized in terms of every type of vitamin, sirlce nawborns cannot compensa-te for vitamin deficiency by consum-ing meat, vegetable or other food.
~ at-soluble v~tamins A) ~2 a~d E are mixed with a ve-~etaole oil1 wherea~ water-soluble vitamins C~ PP, Bl, ~2~ ~3 B6 and Bc are dissolved i~ water or ~ to ~e therea~ter added to the mixture. The amount of vitami~s to be added ~s determi~ed by the average daily infant body needs and the overall amount of ~ product consumed by children up to two months o~ a~e.
It is recommended that corn, coconut, sunf`lower-seed or olive oils are used as the ~egetable ~at.
~ `ha proposed ~our milk product approximates in it~
compo~ition human mil~, and therefore it can be u~ed for ~eeding babie3 during af'ter-birth period9 ~s well as ~or ~eeding premature and newborn childre~. IQ addition, tha~s to a bigh conten~ o~ liv~ bifidobacteria c~lls o~ lU8 to 109 1 o~ the product, ~t can be u~ed as a~ elficient diet ~or childr~ su~'ferirlg from d~bacterios~ or int~stlnal t~o~.
'~he sou~ mil~ product accordiQg to the inre~ion wa~
prescribed by in~a~t cli~ic~ ko premature in~ants and child-re~ batween th~ aKe oY one and four month3 ~ur~ering from irltestirl~1 in~ec~ion of ~a~u~ etiology.
.. ..
rrhe product was i.ntroduced to the premature children diet gradually to eventually .replace the ba~ic ~ood. ~L'he product was ~ed both to "relatively he~lthy" premature new-borns a~d children with d~sbacteriosis treated by vigorous antibiotic therapy. The prematures consumed the product readil~ and gained in weight wit~lout any si~e e~fect~.
A daily three-meals diet of the product was prescrib~d to children sufI`e:rin~ ~ro~ intestinal in~ection for a durati-on of 21 days. ~Jithin thi9 period satisfactory assi~nilation of the sour milk product was evide~ced without any side e~fects or meal reje~ction. A gai~ in ~ei~ht for th~ period of treatment amounted to 300 g per child; paysical condition of the children improved; spewing lessened or ~erminated;
fecal discharge n~alized a~ter 1 to 4 da~s of treatment;
a gro~Yth o~ bifido~lora to 108 _ 109 per 1 g of feces ~vas in evidence.
In view of the foregoi~, t;ie proposed product can be used for Yeeding p~emature newborns and children sufLer-ing from intestinal inrec~ion.
Preparatioa o~ t~e proposed produc~ does not require high cost and acarce materials, or speci~liy designed equip-ment.
~ he method ~or obtaini~ tha proposed sour ml1~ product is suIIiciently siulple and ernploys any known suitable proce~s tachniques involving tne following sta~e~:
- ad~ission, cleanin~ and coolin~ of miik;
- normalization of miLk by cream, - homogenization OL` t~e thus obtai~ed mil; Qase with ve~eta`ole oil ana ~`~t-soluble ~i~ami ns;
. 8 - preparation o~ carbonydrate ingredient~ (sac-,hAro~e an~ malt ext~act) ;
- mixing o~ carbohydrate ingredient with rnilk ~ase;
- sterilization or pasteurization o~ the mixture;
- cooling the mixture to a souring temperature;
- addition to the mixture o~ water-soluble Yitamins and ferrous sulphate;
- ~ermentation and souring of the mixture;
- cooling of the ~inished product;
- bottling, pac~ing and labeli~g;
_ storage.
The following examples are put ~orwar~ herei~below for a better u~derstanding o~ the preser~ invention:
EX~LPLE 1 Added to 387 o~ 3.6 % fat milk and 42.4 kg of 30 ~o fat cream is 9 kg o~ cor~ oil; introduced preliminarily to this corn oil, dependin~ on the concentration in th0 oil ~olution, bein~ fat-soluble vita~ins k, ~2~ a~d ~ in the amou~t~
0.0005, 0~00001, and 0.00851 k~ re~pectiveLy~ :
X~ order to provide ~ finel;y dlspersed ~at emul~io~, the milk-fat ~ase is ho~o~e~lzed at 15-20 hl:Pa and mixed with solu~io~ o~ carbohy~Lrat~ ;redie~ts. The 301uti~ns of ~car-bohydrate l~gredl~t~ are p*epared simultaneou31y wlth ~hc prepar~ion of the m~lk bas~. Powder~d su~ar i~ the amQunt o~
~4.4 ~ and ~.5 kg o~ mal~ extrac~ having 74 '~ of dra matt~r (correspondin~ to 1~ ~ o~ dra dextri~ maltose~ are d~S~ol~d i~ 406~9 ~ o~ potable ~ater heate~ to a ~empera~u~e 48 4' 2~C, ~ilt~red throu~h a coarse ~llter and ~ixed with th~ milk-~a~
z ~ 9 ba~e. 'rhe mixt~e is thcn pa~teurized by exposing ~t to a te~perature 95 ~ 2C durillg 30 rni~utes and cooled to a tem-p~rature 44 ~ 1C.
'~hereàft~r, added to the mixture are 100 kg o~ the fer-menta of pure cultures of bi~idobacteria prepared on a ste-rile fat-free milk, 0.033 kg of f~rrous sulphate and water-solubl0 vitamin~ (solutions in boiled arld cooled water ) C, PP~ B2- B3, B6 , and Bc in the amollnts o~ 0.05, 0.004, 0.0003, 0.0001, 0.0015, 0.0002 and 0.00004, kg respactlvely~
All these ingr~dient~ are thoroughly stirred. The mixture is soured in special ve~sels for sour milk products at a tem-perature o~ 37 ~ 1C to a coagulate acidity of 45 ~ 5C, wherea~ter it is cooled and filled i~to 0.2 1 glass bottles to be stopped and delivered for cool storage.
The ~roduct may be ~tored for up t~ five days at a temperature fro~ 0C to 6C.
~he composition of the thu~ obtained product is as follows, i~ mass per ce~t:
~ilk fat Z~6 vegetabl~ ~at 0.9 qaccharose 3~4 dextri~ maltose 1.7 lacto~e 2.0 ~ater 40.7 protein tha balance, including:
bi~idobacteria, cells }09 ferrou~ sulphate~ mln 1.. ~ 33.0 vitami~s, mln~
A - 0.5 7()~
D2 - 0.01 E. - 8.5 PP ~ 4.0 B~ - 0.3 32 ~ 0.1 - 1~5 ~6 ~ 0~2 Bc ~ 0'04 EXA~PLE ~
Ad~ed to 387 ~g of 3.6 ~0 ~at milk and 4~ ~g 27.1 % ~at c:ream is 8 k~ o~ deodorized ~unflower-seed oil having prelimi-narily~introduced th~reto~ dependi~g on the conceutration in the oil solution, fat-solu~le vitamins A, D2 and E i~ the amounts 0.0005, 0~00001 and 0.0084 kg, respectlvel~.
~or obtainiQg a finely dispersed f~at emulsion the ~ilk-fat base is ho~ogenized at 15 - 20 I~Pa and mixed with so-lutions o~ caxbohydrate ingreaients~ The solutions o~ carbo-hydrate i~redients are prepared simultan~ously with the pr~paratio~ o~ the milk bass. Powdered sug~r i~ th~ amount o~
33 k~ and 24 kæ o~ malt extract:havin~ 78 '~ o~ dry matt~r (correspo~di~g to 18 kg of dr~ dextrln maltose~ are d1~solved in 400~0 kg oY potable watsr war~ed to a temperabure 48 ~ 2~
filtered through;a coarse ~iLter and ~lxed with the~ilk~`at base~ The mixture is pasteurizsd b~ expo3in~ it to~a tempara-~urs of` 95 ~ 24C duriag 30 minutes a~d cooled to 4~ C~
100 ~g o~ the ~rment of pure cultures Or `~iL}~o~cter~a p~-:' pared on a sterile ~at-~ree ~ 00325 kg o~ rrou~ sul~hate, :~ :
3~
and water-soluble vitamins (solutions in boiled a~d cooled ' 1~ B21 ~3, B6 and Bc in the amounts 0.051 0.004, .31 0.0001, 0.0015, 0.0002., and 0.00004 kg ~ res-pectively, are then introduced to the mixtureO All these i~gredie~ts are thoroughly stirred. '~he mixture i.s soured in special vessels for sour milk products at a te~perature of 37 1C to an acidity of 45 5TI1 whereafter it i9 cooled and Yilled into 0.2 1 bo-ttles` to be stopped and delivered ior cool storage. The product can be stored for up to 5 days at a temperature from 0 to 6c.
'~he composition of the thus obtained product is as follows, in mass per cent:
milk fat ~.7 vegetabl~ fat 0.8 saccharose 3.3 dextrin maltose 1.
lactose 2.1 ~iater 40-0 protei~ the balance, inclu~i~g:
bif`idobacteria, cells 109 ~errous sulphate, mln~l 32.5 vitami~s, A - 0~5 D2 - O.01 8, c _ 5 PP - ~.o Bl - 0 . 25 B2 - 0,1 B3 _ 1.5 E~6 ~ 0 . 2 ~ c w o . 04 .
EX~P~E 3 Added to 383.1 kg of 3.6 % :fat milk and 40 kg of` 27.55 %
fat cream i~ lO kg ~f olive oil having prellminarily i~tro-duced thereto, depending on the concentration irl the oil ~olution, fat-soluble vitamir~s A, D2 and E in the amau~t~
of 0.0005, 0.00001 and 0.008 k~,l respectivel;y.
For obtaining a finely dispersed fat emulsiQn the milk-fat basQ i5 homogenized a~ 15 - 20 r/lPa and mi~red with ~olutions of carbohydrats illgredie~ts. ~he solutions o~ car-bohydrate ingredie~ts are prepared sir~ultaneo~uslg with tha preparatio~ of the milk base. Powdared sugar in the amour~t o~
35 ~g and 21.9 kg of malt extract having 74 % ~f dr~ matter ~correspondillg ~o 16.2 kg o~ dr~ dextri~ maltose~ are dissol~ed i~ 410.0 i~g of potable water war~ed to 48 ~ 2G~ filtered through a~coarse ~ilter and mixed ~ith the mil,-~at bass~ The mixtuxe is pasteurized at 95 f 2C during 30 minute~ and cool-ed to ~4 ~ l~C. 100 ~ of tha ferme~t of pure ~ulture o~ bi-fidobacteria prepared on a sterile fat-fr~e mil.s, 0,0335 k~
o~ ~errou~ ~ulphate, and water-solubl~ vitamiRs (solutions in boiled a~d cooled water) C, PP, 13~ B~, B6 and ~c i~ the~
amo~nt o~ 0~04~7 O~OC)4~ 0~0003g O~OOOL~ O~C)017~ Or 0002 a~d O.Q0004 kg, respectlvel~g are then introduced to the mixture, all these bei~g thoroughly stirred, The mixt~e i~ soured i~
,~2;~ Z
-- 13 ~
vessels ;eor ~our mill~ p.roduc ts at 37 ~ 1C to arl acidi ty 0:~ 45 ~ 5~r, whereaIter i t 1~ cooled for bottllng ln 0.2 1 bottles and cool storage where the thus obtained product can be ~tored ~or up to 5 days, at a tempexa-ture of between 0C and 6c >
~he composition of the pro~uct i~ as follows, in mas~
per cent:
milk~~at 2.5 vege t abl e f at 1 . 0 saccharo~e . 3.5 dextrin ~altose 1.6 --lactose 2,0 wRter 41~0 pro~ein the balance, including-biPldobacteria, cells .,,, 108 ferrous sulphate, mln~l 33~S
vitamin~ t mln~
0.5 0~01 E - 8.4 C -49.~ -pp _4 . 0 0, 25
2 ~0,1
3 -1 . 5 6 ~0 . 2 c ~O, 0 7()~3~
EXA~PLE 4 '~he product is obtained according to what h~s been de9c-ribed with reference to Example L to have a composition.rep-resented ~enerally in h~ample 1, except that coconbt oil is used as ve~etable fat.
~ he number of cell.s of bifidobactcria in the product is determined by i.noculatin~ the "Blaurock" medium with limit dilutions o~ the product~
.
`' ;
EXA~PLE 4 '~he product is obtained according to what h~s been de9c-ribed with reference to Example L to have a composition.rep-resented ~enerally in h~ample 1, except that coconbt oil is used as ve~etable fat.
~ he number of cell.s of bifidobactcria in the product is determined by i.noculatin~ the "Blaurock" medium with limit dilutions o~ the product~
.
`' ;
Claims (2)
1. A sour milk product composed of proteins, milk and vegetable fats, lactose, dextrin maltose, saccharose, water, bifidobacteria, ferrous sulphate and vitamins A, D2, E, C, B1, B2, B3, B6, Bc, PP with the following proportion of ingre-dients, in mass per cent:
milk fat 2.5 - 2.7 vegetable fat 0.8 - 1.0 lactose 2.0 - 2.2 dextrin maltose 1.6 - 1.8 saccharose 3.3 - 3.5 water 40.0 - 41.0 protein the balance, including:
bifidobacteria, cells 108 - 109 ferrous sulphate mln-1 32.5 - 33.5 vitamins, mln-1 64.0 - 66Ø
milk fat 2.5 - 2.7 vegetable fat 0.8 - 1.0 lactose 2.0 - 2.2 dextrin maltose 1.6 - 1.8 saccharose 3.3 - 3.5 water 40.0 - 41.0 protein the balance, including:
bifidobacteria, cells 108 - 109 ferrous sulphate mln-1 32.5 - 33.5 vitamins, mln-1 64.0 - 66Ø
2. A sour milk product as defined in claim 1 in which used as vegetable fat is fat from a group including corn, coconut, sunflower-seed and olive oils.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU843706834A SU1351560A1 (en) | 1984-02-29 | 1984-02-29 | Sour milk product "bifilin" |
SU3706834 | 1984-02-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1227082A true CA1227082A (en) | 1987-09-22 |
Family
ID=21105860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000474553A Expired CA1227082A (en) | 1984-02-29 | 1985-02-18 | Sour milk product |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS61501247A (en) |
AU (1) | AU4155485A (en) |
BG (1) | BG46918A1 (en) |
CA (1) | CA1227082A (en) |
CS (1) | CS93585A1 (en) |
DD (1) | DD266921A3 (en) |
DE (2) | DE3590083T (en) |
FI (1) | FI853814A0 (en) |
FR (1) | FR2560013B1 (en) |
GB (1) | GB2171586B (en) |
IT (1) | IT1189721B (en) |
SE (1) | SE451938B (en) |
SU (1) | SU1351560A1 (en) |
WO (1) | WO1985003848A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2673812B1 (en) * | 1991-03-13 | 1994-04-01 | Roussel Uclaf | NOVEL COMPOSITIONS FOR USE IN DIETETICS AND THERAPEUTICS AND CONTAINING A PARTICULAR COMBINATION OF CARBOHYDRATES AND THEIR APPLICATIONS. |
SE9803698L (en) | 1998-10-26 | 2000-04-27 | Ericsson Telefon Ab L M | Methods and devices in a telecommunication system |
US6383534B1 (en) * | 2000-01-18 | 2002-05-07 | Lorin Dyrr | Mineral water composition |
FI123158B (en) * | 2009-05-04 | 2012-11-30 | Valio Oy | Milk protein product and method for its preparation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1948378A1 (en) * | 1969-09-24 | 1971-04-01 | Rolf Dr Schuler | Vitamin-enriched soured milk products |
SU448852A1 (en) * | 1973-06-29 | 1974-11-05 | Институт Питания Академии Медицинских Наук Ссср | Method for the production of dry nutritional formula for feeding young children |
SU483100A1 (en) * | 1973-12-17 | 1975-09-05 | Институт питания АМН СССР | Method for the production of fermented milk nutrient mixture for feeding premature and sick young children |
JPS5283975A (en) * | 1976-01-01 | 1977-07-13 | Yakult Honsha Kk | Method of producing fermented milk product containg living cell of bifidus strain |
CH621048A5 (en) * | 1977-04-27 | 1981-01-15 | Nestle Sa | |
SU663364A1 (en) * | 1977-05-27 | 1979-05-25 | Институт Питания Академии Медицинских Наук | Method of producing paste-like cultured milk product for babies |
SU863639A1 (en) * | 1979-12-25 | 1981-09-15 | Всесоюзный Научно-Исследовательский Институт Молочной Промышленности | Bifidobacterium adoescentis ms-42 strain employed for production of sour-milk productts and method of preparing leaven of bifidobacteria for sour-milk products |
AR231215A1 (en) * | 1982-06-15 | 1984-10-31 | Cpc International Inc | PROCEDURE FOR THE PREPARATION OF AN ACIDIFIED DAIRY PRODUCT AND PRODUCT SO OBTAINED |
-
1984
- 1984-02-29 SU SU843706834A patent/SU1351560A1/en active
-
1985
- 1985-01-25 DE DE19853590083 patent/DE3590083T/en active Pending
- 1985-01-25 JP JP60501478A patent/JPS61501247A/en active Pending
- 1985-01-25 DE DE3590083A patent/DE3590083C2/de not_active Expired - Fee Related
- 1985-01-25 GB GB08523399A patent/GB2171586B/en not_active Expired
- 1985-01-25 WO PCT/SU1985/000010 patent/WO1985003848A1/en active Application Filing
- 1985-01-25 AU AU41554/85A patent/AU4155485A/en not_active Abandoned
- 1985-02-11 CS CS85935A patent/CS93585A1/en unknown
- 1985-02-11 BG BG68787A patent/BG46918A1/en unknown
- 1985-02-12 DD DD85273191A patent/DD266921A3/en not_active IP Right Cessation
- 1985-02-18 CA CA000474553A patent/CA1227082A/en not_active Expired
- 1985-02-27 FR FR858502859A patent/FR2560013B1/en not_active Expired
- 1985-02-28 IT IT41522/85A patent/IT1189721B/en active
- 1985-09-27 SE SE8504488A patent/SE451938B/en not_active IP Right Cessation
- 1985-10-02 FI FI853814A patent/FI853814A0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU4155485A (en) | 1985-09-24 |
IT8541522A0 (en) | 1985-02-28 |
DD266921A3 (en) | 1989-04-19 |
JPS61501247A (en) | 1986-06-26 |
DE3590083T (en) | 1986-03-13 |
FI853814L (en) | 1985-10-02 |
WO1985003848A1 (en) | 1985-09-12 |
GB8523399D0 (en) | 1985-10-23 |
GB2171586B (en) | 1988-06-15 |
GB2171586A (en) | 1986-09-03 |
SE8504488D0 (en) | 1985-09-27 |
BG46918A1 (en) | 1990-04-16 |
DE3590083C2 (en) | 1990-06-21 |
SE451938B (en) | 1987-11-09 |
FR2560013A1 (en) | 1985-08-30 |
IT1189721B (en) | 1988-02-04 |
CS93585A1 (en) | 1988-02-15 |
SU1351560A1 (en) | 1987-11-15 |
SE8504488L (en) | 1985-09-27 |
FR2560013B1 (en) | 1989-12-15 |
FI853814A0 (en) | 1985-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103564044B (en) | A kind of Yoghourt containing marine alga and preparation method thereof | |
CN106465749B (en) | A kind of acidified milk and preparation method thereof containing egg yolk liquid | |
CN103653170A (en) | Stachyose probiotics solid beverage | |
CN103120209A (en) | Chia seed yoghourt, compound yoghourt stabilizer and preparation method of stabilizer | |
CN109953115A (en) | Yoghourt and preparation method thereof | |
CN102578229B (en) | Yoghurt containing hippophae rhamnoides | |
CN109769943A (en) | Seabuckthorn yogurt and preparation method thereof | |
US4756913A (en) | Sour milk product | |
CN102613288A (en) | Yogurt containing fish oil | |
CN108850171A (en) | A kind of soybean protein Yoghourt and preparation method thereof | |
CN101690517A (en) | Soured milk with yolk powder and preparation method thereof | |
US3025165A (en) | Yogurt containing an unsaturated vegetable fat | |
US4511590A (en) | Low-lactose, low-galactose imitation milk product | |
CN102077872B (en) | Fruit vinegar-containing milk beverage and preparation method thereof | |
CA1227082A (en) | Sour milk product | |
CN105815449A (en) | Nostoc health care yoghourt and preparation method thereof | |
CN107836521B (en) | Sophora flower bud yoghourt and preparation method thereof | |
RU2311045C2 (en) | Method for production of biologically active food supplement, method for production of foodstuff and foodstuff (variants) | |
CN104430877A (en) | Production process of passion fruit flavored probiotic yoghourt | |
CN107307080A (en) | A kind of method for production of functional form rice bran Yoghourt | |
RU2280991C2 (en) | Method for yogurt production | |
CN106417609A (en) | Pumpkin seed oil and yellow peach breakfast milk | |
RU2128444C1 (en) | Composition for preparing cultured milk proteinaceous product | |
CN101601423A (en) | A kind of fermentative lactobacillus beverage and preparation method thereof | |
CN105613739A (en) | Preparation method of almond yoghourt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |